Prulifloxacin versus levofloxacin in the treatment of patients with Acute Exacerbations of Chronic Bronchitis AECB

Trial Profile

Prulifloxacin versus levofloxacin in the treatment of patients with Acute Exacerbations of Chronic Bronchitis AECB

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Aug 2016

At a glance

  • Drugs Levofloxacin (Primary) ; Prulifloxacin (Primary)
  • Indications Acute exacerbations of chronic bronchitis; Bacterial infections
  • Focus Therapeutic Use
  • Sponsors Angelini Group
  • Most Recent Events

    • 21 Apr 2012 Planned number of patients changed from 284 to 300 as reported by European Clinical Trials Database record.
    • 29 Jun 2011 New trial record
    • 12 Nov 2010 Status changed from recruiting to completed as reported by EudraCT.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top